COMPARISON OF THE DIAGNOSTIC POTENTIAL OF 4 ECHOCARDIOGRAPHIC STRESS TESTS SHORTLY AFTER ACUTE MYOCARDIAL-INFARCTION - SUBMAXIMAL EXERCISE,TRANSESOPHAGEAL ATRIAL-PACING, DIPYRIDAMOLE, AND DOBUTAMINE-ATROPINE
K. Schroder et al., COMPARISON OF THE DIAGNOSTIC POTENTIAL OF 4 ECHOCARDIOGRAPHIC STRESS TESTS SHORTLY AFTER ACUTE MYOCARDIAL-INFARCTION - SUBMAXIMAL EXERCISE,TRANSESOPHAGEAL ATRIAL-PACING, DIPYRIDAMOLE, AND DOBUTAMINE-ATROPINE, The American journal of cardiology, 77(11), 1996, pp. 909-914
This study assessed and compared the diagnostic potential of submaxima
l exercise, transesophageal atrial pacing, dipyridamole, and dobutamin
e-atropine stress echocardiography tests shortly after acute myocardia
l infarction. In 121 study patients, 325 digital echocardiographic str
ess tests were attempted 10 to 11 days after acute myocardial infarcti
on: 83 submaximal exercise tests, 121 high-dose dipyridamole echocardi
ography tests (DET), 69 transesophageal atrial pacing tests (<150 beat
s/min), and 52 dobutamine tests, starting at 10 mu g/kg per minute, in
creasing stepwise to 40 mu g/kg/min, and coadministering atropine in 1
2 patients (dobutamine-atropine stress echocardiography [DASE]). Resul
ts were correlated to a coronary artery diameter stenosis greater than
or equal to 50% as determined by quantitative angiography. Feasibilit
y to perform submaximal exercise echocardiography, atrial pacing echoc
ardiography, DET, and DASE was 89%, 52%, 98%, and 88%, respectively. A
trial pacing was not tolerated by 18 patients and refused by 6 (9%). S
evere but not life-threatening side effects were hypotension in DET (2
%) and tachyarrhythmias in DASE (6%). Test positivity in multivessel d
isease with submaximal exercise, DET, and DASE was 55%, 93%, and 90%,
respectively, and in 1-vessel disease 47%, 65%, 71%, and for atrial pa
cing, 82%, respectively. We conclude that submaximal exercise has limi
ted sensitivity and atrial pacing limited feasibility. The pharmacolog
ic stressors provide a useful, safe diagnostic approach: DET with slig
htly lower sensitivity in 1-vessel disease and DASE with insignificant
ly less feasibility.